<div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
																		        				
												        				<div  style="width:100%; float:left;  padding-bottom:0px;">
												        					<div	style="width:100%; float:left; min-height:45px; text-align:justify">
												        						<a href="" name="summary_en"></a>
												        						<!--<h2>Summary</h2>-->
												        						<h3>
	Abstract</h3>
<p>
	<strong style="font-family: Tahoma; margin: 0px; padding: 0px; line-height: 1.3; color: rgb(50, 50, 50); text-align: justify;">Background</strong><span style="color: rgb(50, 50, 50); font-family: Tahoma; text-align: justify;">: The emergence of infections due to multidrug-resistant Gram-negative bacilli (MDR-GNB) has led to the resurrection of colistin use. The data on colistin use and drug-related adverse effects in children are scarce.</span></p>
<p>
	<strong style="font-family: Tahoma; margin: 0px; padding: 0px; line-height: 1.3; color: rgb(50, 50, 50); text-align: justify;">Aims</strong><span style="color: rgb(50, 50, 50); font-family: Tahoma; text-align: justify;">: In this study, we aimed to evaluate the clinical efficacy and safety of colistin use in critically ill pediatric patients.</span></p>
<p>
	<strong style="font-family: Tahoma; margin: 0px; padding: 0px; line-height: 1.3; color: rgb(50, 50, 50); text-align: justify;">Study Design</strong><span style="color: rgb(50, 50, 50); font-family: Tahoma; text-align: justify;">: This study has a retrospective study design.</span></p>
<p>
	<strong style="font-family: Tahoma; margin: 0px; padding: 0px; line-height: 1.3; color: rgb(50, 50, 50); text-align: justify;">Methods</strong><span style="color: rgb(50, 50, 50); font-family: Tahoma; text-align: justify;">: Sixty-one critically ill children were identified through the department&rsquo;s patient files archive during the period from January 2011 to November 2014.</span></p>
<p>
	<strong style="font-family: Tahoma; margin: 0px; padding: 0px; line-height: 1.3; color: rgb(50, 50, 50); text-align: justify;">Results</strong><span style="color: rgb(50, 50, 50); font-family: Tahoma; text-align: justify;">: Twenty-nine females and thirty-two males with a mean&plusmn;standard deviation (SD) age of 61&plusmn;9 months (range 0-216, median 12 months) received IV colistin due to MDR-GNB infections. Bacteremia (n=23, 37.7%) was the leading diagnosis, followed by pneumonia (n=19, 31%), clinical sepsis (n=7, 11.4%), wound infection (n=6, 9.8%), urinary tract infection (n=5, 8.1%) and meningitis (n=1, 1.6%). All of the isolates were resistant to carbapenems; however, all were susceptible to colistin. The isolated microorganisms in decreasing order of frequency were: Acinetobacter baumanni (n=27, 44.2%), Pseudomonas aeruginosa (n=17, 27.8%), Klebsiella pneumoniae (n=6, 9.8%), K. pneumoniae and Stenotrophomonas maltophilia (n=1, 1.6%), K. pneumoniae and A. baumanni (n=1, 1.6%), K. oxytoca (n=1, 1.6%) and Enterobacter cloacae (n=1, 1.6%). In seven patients, no microorganisms were detected; however, five of these patients were colonized by carbapenem-resistant K. pneumoniae. The mean duration of colistin therapy was 12 days (range 3-45). Colistin was administered concomitantly with one of the following antibiotics: carbapenem (n=50, %82), ampicillin-sulbactam (n=5, 8%), quinolones (n=5, 8%), rifampicin (n=1, 1.6%). Carbapenem was the most frequently used antibiotic. Nephrotoxicity was observed in only 1 patient, and we did not observe neurotoxicity in this study. All the patients received intravenous colistin (colisthimethate)&nbsp; at a dosage of 5 mg/kg daily by dividing it in three equal doses. Seven (11.4%) patients died during the study period.</span></p>
<p>
	<strong style="font-family: Tahoma; margin: 0px; padding: 0px; line-height: 1.3; color: rgb(50, 50, 50); text-align: justify;">Conclusion</strong><span style="color: rgb(50, 50, 50); font-family: Tahoma; text-align: justify;">: Colistin appears to be a safe and efficacious drug for treating MDR-GNB infections in children.</span></p>
												        					</div>
												        					<!--
												        					<div	style="width:20%; float:left; min-height:150px; padding:10px; padding-top:40px;">
												        									<a class="selected_menu" href="#summary_en">Summary</a>												        					</div>
												        					-->
												        				</div>
												        				
												        				
												        															        			
		
											        	</div>